Extracellular vesicle (EV)-mediated neuroinflammation is increasingly recognized as a critical driver in the progression of AD, with mechanisms intricately linked to carboxyl-terminal fragments (CTFs) of amyloid precursor protein (APP). The gene discussed is APP; the disease is Alzheimer disease.